Basics of Pharmaceutical Emulsion: A Review
Abstract
Pharmaceutical formulations are usually supplied in the form of emulsions for treating skin disorders and skin protection. This method of pharmaceutical treatment is thermodynamically unstable and needs to be stabilized by the application of an emulsifier. Emulsified solutions vary from lotions that have relatively low viscosity to more viscous creams. There are two basic types of emulsion, oil in the Water (O/W), and oil (W/O) water, respectively. Besides these two forms, there is another fairly complex emulsion, called multiple emulsions. Generally, emulsions have some benefits over certain types of treatment, as the solubilized drug could be more bioavailable. Besides, gastrointestinal problems and metabolic effect at the first pass are also avoided, oil in water (O/W), water in oil (W/O).
How to cite this article: Pooni N. Basics of Pharmaceutical Emulsion: A Review. J Durg Dis Dev 2019; 3(2): 10-12.
References
Nimberkar TP, Wanjari BE, Sanghi DK et al. Formulation and Evaluation of Sustained Release Multiple Emulsion of Hydroxy progesterone. Int J Pharm and Pharm.
Vyas SP, Khar RK. Targeted & Controlled Drug Delivery-Novel Carrier Systems. CBS Publishers & Distributors, 1st Edtn.
Herbert AL, Martin MR, Gilbert SB. Pharmaceutical Emulsions and Microemulsions, Pharmaceutical Dosage Forms Disperse Systems. Marcel Dekker, INC, New York and Basel, USA. 1996.
Javed A, Sanjula B, Alka A. Emulsion. Available at: http//Javed- Ali.Tripod.Com. John EH (1976). Dispensing of Medication, Mack Publishing Company. 2008.
Nasirideen S, Kas HS, Oner F et al. Naproxen incorporated lipid emulsions. I. Formulation and stability studies. J Clinical Pharma Therapeut 1998.
Nita A, Rouzhou H, Richard AW. Performance of a rotating membrane emulsifier for production of coarse droplets. J Membrane 2009.
Lachman L, Lieberman HA. The Theory & Practice of Industrial Pharmacy. CBS Publishers & Distributors. 2009.
Kumar R, Kumar M, Mahadevan N. Multiple Emulsions: A Review. Int J Recent Adv Pharm Research.
Jain NK. Advances in Controlled and Novel Drug Delivery. CBS Publishers & Distributors, 1st Edtn.
Cerpnjak K, Zvonar A, Gašperlin M et al. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Odriozola-Serrano I, Oms-Oliu G, Martín-Belloso O. Nano emulsion-based delivery systems to improve functionality of lipophilic components.
Mc Clements DJ. Nano emulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.
Wu Y, Li YH, Gao XH, Chen HD. The application of nano emulsion in dermatology: an overview. J Drug Target.
Kotta S, Khan AW, Pramod K et al. Exploring oral nano emulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
